Editors' ChoiceRETINAL DEGENERATION

Anti-VEGF AAV2 injections: The fewer the better

+ See all authors and affiliations

Science Translational Medicine  07 Jun 2017:
Vol. 9, Issue 393, eaan4921
DOI: 10.1126/scitranslmed.aan4921

You are currently viewing the abstract.

View Full Text

Abstract

A single intravitreal injection of AAV2 provides sustained delivery of anti-VEGF protein for the treatment of neovascular AMD.

View Full Text